Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.40 | 2.30 | 2.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 2.40 | 2.40 | 2.40 | 14,156 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -2.53 | 13.04M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 05/11/2024 | 10:57 | ALNC |  *Genedrive featured in UK Department for Business & Trade's genomics.. |
| 05/11/2024 | 10:53 | UK RNS | Genedrive PLC Department for Business and Trade feature |
| 04/11/2024 | 13:29 | UK RNS | Genedrive PLC Scottish Health Technology Group publications |
| 21/10/2024 | 14:22 | UK RNS | Genedrive PLC Director Declaration |
| 15/8/2024 | 09:39 | UK RNS | Genedrive PLC Director/PDMR Shareholding |
| 12/8/2024 | 06:00 | UK RNS | Genedrive PLC First UK commercial sales of the CYP2C19-ID Kit |
| 06/8/2024 | 13:36 | ALNC | Genedrive CEO leaves after less than a year; promotes CSO Miele to CEO |
| 06/8/2024 | 06:00 | UK RNS | Genedrive PLC Directorate Change |
| 31/7/2024 | 06:00 | UK RNS | Genedrive PLC NICE recommends CYP2C19-ID Kit in final guidance |
| 15/7/2024 | 18:36 | ALNC | EARNINGS AND TRADING: Genedrive in FDA boost; Bango revenue rises |
1 Year Genedrive Chart |
Intraday Genedrive Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
